QAA

2-phenyl-N-{6-[4-({6-[(phenylacetyl)amino]pyridazin-3-yl}oxy)piperidin-1-yl]pyridazin-3-yl}acetamide

Created:	2019-10-09
Last modified:	2020-10-14

Find Related PDB Entry
1 entries where QAA is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	0
Bond Count	72
Aromatic Bond Count	24

2D diagram of QAA

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-phenyl-N-{6-[4-({6-[(phenylacetyl)amino]pyridazin-3-yl}oxy)piperidin-1-yl]pyridazin-3-yl}acetamide
Systematic Name (OpenEye OEToolkits)	2-phenyl-~{N}-[6-[4-[6-(2-phenylethanoylamino)pyridazin-3-yl]oxypiperidin-1-yl]pyridazin-3-yl]ethanamide
Formula	C₂₉ H₂₉ N₇ O₃
Molecular Weight	523.586
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c1cc(nnc1NC(Cc2ccccc2)=O)OC5CCN(c3nnc(cc3)NC(=O)Cc4ccccc4)CC5
SMILES	CACTVS	3.385	O=C(Cc1ccccc1)Nc2ccc(OC3CCN(CC3)c4ccc(NC(=O)Cc5ccccc5)nn4)nn2
SMILES	OpenEye OEToolkits	2.0.7	c1ccc(cc1)CC(=O)Nc2ccc(nn2)N3CCC(CC3)Oc4ccc(nn4)NC(=O)Cc5ccccc5
Canonical SMILES	CACTVS	3.385	O=C(Cc1ccccc1)Nc2ccc(OC3CCN(CC3)c4ccc(NC(=O)Cc5ccccc5)nn4)nn2
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc(cc1)CC(=O)Nc2ccc(nn2)N3CCC(CC3)Oc4ccc(nn4)NC(=O)Cc5ccccc5
InChI	InChI	1.03	InChI=1S/C29H29N7O3/c37-27(19-21-7-3-1-4-8-21)30-24-11-13-26(34-32-24)36-17-15-23(16-18-36)39-29-14-12-25(33-35-29)31-28(38)20-22-9-5-2-6-10-22/h1-14,23H,15-20H2,(H,30,32,37)(H,31,33,38)
InChIKey	InChI	1.03	IDGBGPKCEIHLHR-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3770102
PubChem	121256316
ChEMBL	CHEMBL3770102

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.